| Filed | Description | |
|---|---|---|
| 3/4/26 | 1.01 Material Agreement | → |
| 12/17/25 | 1.01 Material Agreement | → |
| 10/14/25 | 1.01 Material Agreement | → |
| 9/30/25 | 1.01 Material Agreement | → |
| 9/18/25 | 1.01 Material Agreement | → |
| 6/26/25 | 1.01 Material Agreement | → |
| ↓ 14 more | ||
MAIA Biotechnology, Inc. is a public, immune-oncology company based in Chicago, IL focused on the development of telomere targeting agents for the treatment of telomerase-positive cancer cells.